PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for January 3, 2006 Add to my Yahoo! Subscribe to this News Feed Subscribe to this News Feed   Subscribe to this Podcast Feed PodcastiTunes
 

Baxa Ltd Announces Direct Sales and Marketing Operations in France and Benelux

Baxa Ltd, subsidiary of Denver-based Baxa Corporation, has moved to a direct sales and marketing model for the French and Benelux markets. The company provides systems and devices for simplifying the handling, mixing and administration of fluid medications.

Ascot, UK (PRWEB) January 3, 2006 -- Baxa Ltd announces its move to direct sales and marketing operations in France, Belgium, The Netherlands and Luxembourg beginning January 1st 2006. In the ten years previous, Baxa products were sold primarily through exclusive distributors in these countries, with customer and technical support provided by Baxa Ltd from their European Headquarters in Ascot, Berkshire.

“These changes present us with huge opportunities to build on the successes of our Distributor partners and improve both our service and our products through a closer understanding of customer needs,’ says Terry Aston, Managing Director, Baxa Ltd.

The move to a direct sales model promotes the company’s strategy of fostering close customer relationships and strengthens Baxa Ltd’s presence in these countries. Baxa currently has direct sales operations in the United Kingdom, Denmark and Germany, and supports distribution partners in 16 other countries in Europe, the Middle East and Africa. Product distribution across mainland Europe will be handled via a European warehouse hub in Gent in Belgium, where customer orders will be processed and shipped.

“We are working closely with our Distributors to ensure the transition will be seamless from a customer perspective,” states Brendan Parker, Baxa Ltd Sales and Marketing Director. “We look forward to continuing the excellent customer support previously provided by our Distributors.”

Baxa Ltd provides systems and products that streamline pharmacy operations for oral liquid delivery, sterile IV preparation and mixing multi-source parenteral solutions. The company’s products provide solutions for enhancing patient safety, improving drug preparation procedures and reducing the opportunity for medication errors. The UK operation is a subsidiary of Baxa Corporation, based in Colorado.

About Baxa Corporation

Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Privately held, Baxa Corporation has subsidiaries in Canada, the United Kingdom, sales infrastructure in Germany and Denmark, and distribution partners worldwide. Further information is available at http://www.baxa.com.

Contacts:
Stephanie Scott
Baxa Ltd: Tel +44 (0)1344 890916

Maggie Chamberlin Holben, APR
Absolutely Public Relations: 303.984.9801 or 303.669.3558

# # #

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SGFsZi1NYWduLUZhbHUtUHJvZi1TcXVhLVplcm8=

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Printer Friendly Version
Adobe PDF Download PDF Version
Adobe PDF Download Reader Version
Email Email this story to a colleague
CONTACT INFORMATION
Maggie Holben
ABSOLUTELY PUBLIC RELATIONS
303-984-9801
Email us Here
View Our Newsroom
ATTACHED FILES

Baxa Corporation
Englewood, CO USA

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.